Key statistics
On Friday, Perspective Therapeutics Inc (CATX:ASQ) closed at 13.47, -29.29% below its 52-week high of 19.05, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.96 |
---|---|
High | 14.19 |
Low | 13.34 |
Bid | 13.37 |
Offer | 14.15 |
Previous close | 13.35 |
Average volume | 941.04k |
---|---|
Shares outstanding | 67.43m |
Free float | 53.66m |
P/E (TTM) | -- |
Market cap | 900.16m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
- Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024
- Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in September
- Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
- Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results
- Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
- Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
- Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
- Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Perspective Therapeutics to Participate at Upcoming May Investor Conferences
More ▼